| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dopamine receptor D5 | 0.603 | 0.423 | 1.3E-16 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2004 | ||||||||
|
kynurenine aminotransferase 3 | 0.760 | 0.269 | 7.1E-16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
acyl-CoA synthetase medium chain family member 1 | 0.769 | 0.269 | 2.3E-15 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
interferon regulatory factor 7 | 0.547 | 0.846 | 4.5E-15 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ER degradation enhancing alpha-mannosidase like protein 1 | 0.760 | 0.269 | 1.1E-13 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
adenine phosphoribosyltransferase | 0.423 | 0.846 | 5.5E-13 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
neural EGFL like 1 | 0.539 | 0.731 | 8.7E-12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
arylsulfatase A | 0.448 | 0.923 | 1.1E-11 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
solute carrier family 6 member 13 | 0.736 | 0.346 | 1.2E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ghrelin and obestatin prepropeptide | 0.517 | 0.769 | 1.4E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.370 | None | 0.600 | 5 | 0 | 2007 | 2017 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit V1 | 0.617 | 0.538 | 6.4E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
DIX domain containing 1 | 0.647 | 0.385 | 7.3E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2014 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2003 | 2013 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
PTEN induced kinase 1 | 0.516 | 0.769 | 1.9E-10 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
GEM interacting protein | 0.890 | 0.038 | 1.9E-10 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
tryptophan 2,3-dioxygenase | 0.599 | 0.654 | 2.0E-10 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2006 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1997 | 2020 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2002 | 2015 | ||||||||
|
ferritin light chain | 0.559 | 0.692 | 1.7E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 |